Wells Fargo & Company Becton Dickinson & CO Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Becton Dickinson & CO stock. As of the latest transaction made, Wells Fargo & Company holds 1,454,376 shares of BDX stock, worth $326 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,454,376

Previous 1,475,778 1.45%

Holding current value

$326 Million

Previous $345 Million 1.67%

% of portfolio

0.08%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$221.47 - $242.41 $4.74 Million - $5.19 Million	-21,402 Reduced 1.45%	1,454,376 $351 Million
Q2 2024 Aug 13, 2024	SELL	$225.07 - $246.17 $51 Million - $55.8 Million	-226,660 Reduced 13.31%	1,475,778 $345 Million
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $474 Million - $503 Million	-2,031,469 Reduced 54.41%	1,702,438 $421 Million
Q4 2023 Feb 09, 2024	SELL	$232.24 - $267.23 $12.1 Million - $13.9 Million	-52,037 Reduced 1.37%	3,733,907 $910 Million
Q3 2023 Nov 13, 2023	SELL	$254.9 - $283.59 $4.92 Million - $5.47 Million	-19,285 Reduced 0.51%	3,785,944 $979 Million
Q2 2023 Aug 15, 2023	SELL	$238.39 - $265.32 $1.93 Million - $2.15 Million	-8,093 Reduced 0.21%	3,805,229 $1 Billion
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $2.72 Million - $3.07 Million	11,841 Added 0.31%	3,813,322 $944 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $10.3 Million - $12.1 Million	47,096 Added 1.25%	3,801,481 $967 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $1.08 Million - $5.61 Million	21,224 Added 0.57%	3,754,385 $837 Million
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $15.6 Million - $18.3 Million	-66,281 Reduced 1.74%	3,733,161 $920 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $73 Million - $81 Million	299,551 Added 8.56%	3,799,442 $1.01 Billion
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $15 Million - $16.4 Million	-65,369 Reduced 1.83%	3,499,891 $880 Million
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $2.86 Million - $3.15 Million	12,298 Added 0.35%	3,565,260 $876 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $32.2 Million - $35.3 Million	-138,498 Reduced 3.75%	3,552,962 $864 Million
Q1 2021 May 13, 2021	SELL	$232.09 - $256.88 $25.9 Million - $28.7 Million	-111,572 Reduced 2.93%	3,691,460 $898 Million
Q4 2020 Feb 09, 2021	BUY	$221.92 - $245.94 $35 Million - $38.8 Million	157,793 Added 4.33%	3,803,032 $952 Million
Q3 2020 Nov 05, 2020	SELL	$215.77 - $276.76 $9.35 Million - $12 Million	-43,335 Reduced 1.17%	3,645,239 $848 Million
Q2 2020 Aug 13, 2020	BUY	$219.9 - $263.41 $22.7 Million - $27.2 Million	103,430 Added 2.88%	3,688,574 $883 Million
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $702 Million - $1 Billion	3,585,144 New	3,585,144 $824 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Becton Dickinson & CO Transaction History